Decent Holding Inc. Announces First Half of Fiscal Year 2026 Financial Results

Decent Holding Inc. Announces First Half of Fiscal Year 2026 Financial Results Decent Holding Inc. Announces First Half of Fiscal Year 2026 Financial Results GlobeNewswire August 04, 2026

YANTAI, China, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Decent Holding Inc. (NASDAQ: DXST) (“Decent” or the “Company”), a technology-driven provider of wastewater treatment and community-based senior health and elderly care services in China, today announced its unaudited financial results for the six months ended April 30, 2026.

Financial Highlights for the First Half of Fiscal Year 2026

Selected Financial Results for the First Half of Fiscal Year 2026

Total Revenue

Total revenue increased by 238.0%, or approximately $13.1 million, to approximately $18.6 million for the six months ended April 30, 2026, compared with approximately $5.5 million for the six months ended April 30, 2025. Revenue growth was primarily attributable to the expansion of existing business lines and the incremental contribution from the newly launched digital health and wellness segment, which mainly includes training services and product sales.

Wastewater Treatment Revenue

Wastewater treatment revenue increased by 1,762.8% to approximately $9.2 million for the six months ended April 30, 2026, from approximately $0.5 million in the prior-year period, primarily reflecting successful bids and project completions. Gross profit from wastewater treatment revenue increased to approximately $2.0 million, and gross margin improved to 21.4% from 18.6%.

River Water Quality Management Revenue

River water quality management revenue decreased by 9.1% to approximately $4.3 million for the six months ended April 30, 2026, from approximately $4.7 million in the prior-year period. Gross margin for this revenue category was 23.5%, compared with 27.6% in the prior-year period.

Product Sales Revenue

Product sales revenue increased by 385.4% to approximately $1.3 million for the six months ended April 30, 2026, from approximately $0.3 million in the prior-year period. The increase was driven by higher sales volume of microbial inoculum products and contributions from the newly added digital health business line. Gross margin for product sales was 25.3%, compared with 41.7% in the prior-year period, reflecting pricing adjustments and revenue mix.

Training Revenue

Training revenue, which was generated by the Company’s newly launched digital health business segment, contributed approximately $3.5 million for the six months ended April 30, 2026. Training revenue generated gross profit of approximately $2.6 million and gross margin of 75.1%.

Cost of Revenue

Cost of revenue increased by 210.6% to approximately $12.4 million for the six months ended April 30, 2026, from approximately $4.0 million in the prior-year period, primarily in line with the increase in revenue.

Gross Profit and Gross Margin

Gross profit increased by 310.3% to approximately $6.2 million for the six months ended April 30, 2026, from approximately $1.5 million in the prior-year period. Gross margin increased to 33.4% from 27.5%, primarily attributable to an improved revenue mix, including the high-margin contribution from the Company’s newly launched digital health business line and scale efficiencies in wastewater treatment services.

Operating Expenses

Operating expenses increased by 257.9% to approximately $7.1 million for the six months ended April 30, 2026, from approximately $2.0 million in the prior-year period. The increase was mainly due to higher selling expenses associated with marketing for the Company’s newly launched digital health business line, increased consultant and service fees, higher salary and welfare expenses following internal personnel adjustments, and increased research and development expenses related to external research initiatives.

Net Loss

Net loss was approximately $1.1 million for the six months ended April 30, 2026, compared with net loss of approximately $0.5 million for the six months ended April 30, 2025. Net loss margin narrowed to 5.8% from 8.7% in the prior-year period.

Cash and Equivalents

As of April 30, 2026, the Company had cash of approximately $1.7 million, compared with approximately $0.6 million as of October 31, 2025. Net cash provided by financing activities was approximately $7.0 million for the six months ended April 30, 2026.

Recent Developments

On March 16, 2026, the Company effected a one-for-twenty-five share consolidation of its Class A ordinary shares and Class B ordinary shares. All share and per share amounts presented in this release have been retroactively restated to give effect to the share consolidation.

In March 2026, Suncare launched its digital senior health and elderly care platform. On March 10, 2026, Suncare entered into a strategic cooperation agreement with a regional senior care operator in China, which is expected to expand the platform by approximately 70 additional community service locations across several provinces in eastern and northern China. On June 9, 2026, the Company entered into a partnership with Taihao Robotics to establish a robotics training network in China.

In November 2025, the Company completed a registered offering of its Class A ordinary shares and accompanying warrants for gross proceeds of approximately $8.0 million, before deducting placement agent fees and offering expenses. On April 24, 2026, the Company filed a registration statement on Form F-3, which was declared effective on May 8, 2026.

On July 14, 2026, the Company’s shareholders approved an increase in the Company’s authorized share capital and authorized the board of directors to effect one or more share consolidations within specified ratios within one year of the meeting, together with related amendments to the Company’s memorandum and articles of association.

Suncare Business Overview and Strategic Progress

Suncare is the Company's AI-powered, community-based senior health and elderly care platform, integrating community service locations with digital health technologies, intelligent devices, robotics and home-based care services. Since its launch in March 2026, Suncare has expanded to approximately 480 community service locations and approximately 150,000 paid members as of June 30, 2026. During the first half of fiscal 2026, the Company's digital health business generated approximately $3.5 million in training revenue with a gross margin of 75.1%, providing an early contribution to revenue growth and improving the Company's overall business mix.

Looking ahead, the Company intends to continue expanding Suncare's community service network while strengthening its digital health platform, strategic partnerships and technology capabilities. By integrating AI-enabled health management, intelligent devices, robotics and community-based healthcare services, the Company aims to build a scalable senior healthcare ecosystem and establish an additional long-term growth platform alongside its environmental services business.

Chairman's Commentary

Mr. Dingxin Sun, Chairman of Decent Holding Inc., commented: "Our first-half fiscal 2026 results reflect strong revenue growth and the early contribution from our strategic expansion into senior health and elderly care services. Total revenue reached approximately $18.6 million, exceeding our revenue for the full fiscal year ended October 31, 2025, while gross margin improved to 33.4% as our revenue mix benefited from high-margin training services and continued growth in our environmental services business."

"We are encouraged by the early progress of Suncare. Since its launch in March 2026, the platform has grown to approximately 480 community service locations and approximately 150,000 paid members, while generating approximately $3.5 million in training revenue during the first half of fiscal 2026. We believe this expanding community network provides a solid foundation for developing an AI-powered senior healthcare ecosystem integrating digital health, intelligent devices, robotics and home-based care services. Looking ahead, we will continue executing our environmental services strategy while prudently investing in Suncare to support sustainable long-term growth and shareholder value creation."

About Decent Holding Inc.

Decent Holding Inc. (NASDAQ: DXST) specializes in the provision of wastewater treatment by cleansing industrial wastewater, ecological river restoration and river ecosystem management by enhancing water quality, as well as microbial products primarily used for pollutant removal and water quality enhancement, through the Company's operating subsidiary, Shandong Dingxin Ecology Environmental Co., Ltd. In addition, through its operating subsidiary Suncare (Shanghai) Health Technology Co., Ltd., the Company operates an AI-powered, community-based senior health and elderly care platform serving China's aging population. For more information, please visit: https://ir.dxshengtai.com.

Forward-Looking Statements

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “could,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “intends,” “views,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; our ability to open and operate new community service centers on our anticipated timeline; our ability to attract and retain paid members; the development and deployment of AI-enabled technologies and related services; the regulatory environment applicable to healthcare and elderly care services in China; and the evolving PRC legal and regulatory framework governing data privacy, data security, and cross-border data transfers. For a more detailed discussion of these and other risks, you should review the risk factors and other disclosures contained in our filings with the U.S. Securities and Exchange Commission, including our most recent annual report on Form 20-F. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law.

Investor Relations Contact:
WFS Investor Relations Inc.
Connie Kang, Partner
Email: ckang@wfsir.com
Tel: +86 1381 185 7742 (CN)


DECENT HOLDING INC. AND SUBSIDIARIES
UNAUDITED INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
(Stated in U.S. dollars, except for share and per share data)
       
  As of
April 30,
2026
  As of
October 31,
2025
 
  Unaudited    
ASSETS      
CURRENT ASSETS      
Cash $1,653,308  $572,807 
Accounts receivable, net  21,270,035   12,382,623 
Prepayment, net  5,582,523    
Prepaid expenses, current  1,107,696   1,963,359 
Other Receivables  113,118   5,073 
Contract assets  1,838,135   1,158,370 
Loan receivable, current  600,000    
Due from related parties  347   490 
Inventories  123   128 
Interest receivable  3,500   10,500 
Total current assets  32,168,785   16,093,350 
NON-CURRENT ASSETS        
Deferred offering costs     19,884 
Prepaid expenses, non-current     105,000 
Loan receivable, non-current     350,000 
Operating lease assets, net  760,269   154,556 
Property and equipment, net  179,688   201,539 
Intangible assets, net  5,798   5,738 
Deferred tax asset  411,177   248,908 
Total non-current assets  1,356,932   1,085,625 
TOTAL ASSETS $33,525,717  $17,178,975 
         
LIABILITIES AND SHAREHOLDERS’ EQUITY        
CURRENT LIABILITIES        
Accounts payable $7,560,733  $3,175,565 
Advance from Customers  1,044,553   246 
Payroll payable  89,959   15,009 
Tax payables  1,548,762   1,138,911 
Other payables  7,241,937   5,005,375 
Contract liabilities  1,256,381    
Operating lease liabilities – current  290,326   52,217 
Estimated warranty liabilities  120,161   9,650 
Total current liabilities  19,152,812   9,396,973 
NON-CURRENT LIABILITIES        
Operating lease liabilities – non-current  426,626   54,331 
Total non-current liabilities  426,626   54,331 
TOTAL LIABILITIES  19,579,438   9,451,304 
         
SHAREHOLDERS’ EQUITY        
Class A Ordinary shares (US$0.0025 par value, 19,800,000 shares authorized, 1,615,128 and 450,000 shares issued and outstanding as of April 30, 2026 and October 31, 2025, respectively)  4,038   1,125 
Class B Ordinary shares (US$0.0025 par value, 200,000 shares authorized, 200,000 shares issued and outstanding as of April 30, 2026 and October 31, 2025, respectively)  500   500 
Subscription receivable  (1,500)  (1,500)
Additional paid-in capital  11,257,406   4,222,882 
Statutory reserve  666,232   512,732 
Retained earnings  1,893,290   3,118,706 
Accumulated other comprehensive income (loss)  128,530   (126,774)
Total Decent’s shareholders’ equity  13,948,496   7,727,671 
Non-controlling interests  (2,217)   
Total shareholders’ equity  13,946,279   7,727,671 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $33,525,717  $17,178,975 
         


DECENT HOLDING INC. AND SUBSIDIARIES
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATION AND COMPREHENSIVE (LOSS) INCOME
(Stated in U.S. dollars, except for share and per share data)
    
  For The Six Months Ended
April 30,
 
  2026  2025 
REVENUE      
Wastewater treatment revenue $9,186,084  $493,123 
River water quality management revenue  4,297,180   4,728,449 
Product sales revenue  1,344,830   277,081 
Training revenue  3,502,890    
Others  254,541    
TOTAL REVENUE  18,585,525   5,498,653 
         
COST OF REVENUE        
Wastewater treatment revenue  (7,220,924)  (401,310)
River water quality management revenue  (3,288,423)  (3,424,737)
Product sales revenue  (1,004,580)  (161,511)
Training revenue  (872,309)   
TOTAL COST OF REVENUE  (12,386,236)  (3,987,558)
GROSS PROFIT  6,199,289   1,511,095 
         
OPERATING EXPENSES        
Selling expenses  (3,076,861)  (223,821)
General and administrative expenses  (3,809,799)  (1,740,278)
Research and development expenses  (188,381)  (12,784)
Total operating expenses, net  (7,075,041)  (1,976,883)
         
NET LOSS FROM OPERATIONS  (875,752)  (465,788)
         
OTHER INCOME (EXPENSES)        
Interest income  7,595   13,854 
Other income  27   2,521 
Total other income, net  7,622   16,375 
         
NET LOSS BEFORE TAXES  (868,130)  (449,413)
         
Income tax expenses  (205,963)  (29,752)
NET LOSS  (1,074,093)  (479,165)
Net loss attributable to non-controlling interests  (2,177)   
Net loss attributable to shareholders  (1,071,916)  (479,165)
         
OTHER COMPREHENSIVE (LOSS) INCOME        
Foreign currency translation adjustment attributable to non-controlling interests  (40)   
Foreign currency translation adjustment attributable to shareholders  255,304   (131,684)
Total comprehensive income (loss)  255,264   (131,684)
COMPREHENSIVE LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS $(2,217) $ 
COMPREHENSIVE LOSS ATTRIBUTABLE TO DECENT’S SHAREHOLDERS $(816,612) $(610,849)
         
Weighted average shares outstanding during the year – basic and diluted  1,744,319   650,000 
Loss per Ordinary Share – basic and diluted $(0.61) $(0.74)
         


DECENT HOLDING INC. AND SUBSIDIARIES
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Stated in U.S. dollars, except for share and per share data)
    
  For The Six Months Ended
April 30,
 
  2026  2025 
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $(1,074,093) $(479,165)
Adjustments to reconcile net loss to net cash used in operating activities:        
Allowance for credit losses and bad debts  791,245   789,852 
Depreciation and amortization  46,465   36,951 
Amortization of finance lease assets     7,306 
Non-cash operating lease expenses  99,636   27,149 
Deferred income tax effect  (148,914)  (113,869)
Estimated warranty effect  108,073   (27,040)
Changes in operating assets and liabilities:        
Accounts receivable  (8,999,285)  (651,784)
Prepayment  (2,018,193)  7,540 
Prepaid expenses  936,428    
Other receivables  (105,843)  6,463 
Contract assets  (4,119,007)  2,683 
Due from related party  161   264 
Inventories  11   2 
Other current assets     (1,188,411)
Tax payables  354,877   143,621 
Other payables  1,986,935   632,182 
Accounts payable  4,173,124   (703,567)
Advance from customers  1,025,049    
Contract liabilities  1,233,224    
Operating lease liabilities  (93,034)  (6,511)
Advance from related parties     (55,035)
Payroll payable  72,943   11,390 
CASH USED IN OPERATING ACTIVITIES  (5,730,198)  (1,559,979)
         
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchase of property and equipment  (16,445)  (585)
Loan made to third party  (243,000)  (1,984,087)
Repayment from related parties     38,901 
CASH USED IN INVESTING ACTIVITIES  (259,445)  (1,945,771)
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Offering costs paid  (962,563)  (1,017,291)
Principal payment for obligation under finance leases     (11,695)
Gross proceeds from offering  8,000,000   5,000,000 
CASH PROVIDED BY FINANCING ACTIVITIES  7,037,437   3,971,014 
         
EFFECT OF EXCHANGE RATE ON CASH  32,707   (33,880)
         
NET CHANGE IN CASH  1,080,501   431,384 
         
CASH AT BEGINNING OF PERIOD  572,807   407,031 
         
CASH AT END OF PERIOD $1,653,308  $838,415 
         
SUPPLEMENTAL CASH FLOW INFORMATION        
Cash paid during the period for:        
Income taxes $  $ 
Interest $  $ 
         
NON-CASH TRANSACTIONS        
Operating lease assets obtained in exchange for lease obligations $687,751  $ 
Cashless exercise of warrants  1,579